ICD-10-CM Billable Code

A23.3

Brucellosis due to Brucella canis

Clinical Classification Guidelines

Medical Intelligence & Overview

Brucellosis due to Brucella canis, classified under ICD-10 code A23.3, is an infectious disease transmitted from dogs to humans. This disease is caused by the bacteria Brucella canis, which primarily infects dogs but can sometimes spread to humans, leading to a range of health issues. Recognizing the signs, understanding the causes, and knowing about diagnosis and treatment options can help in managing this condition effectively.

Causes & Symptoms

Clinical Causes: The primary cause of brucellosis due to Brucella canis is exposure to infected dogs, particularly through contact with their bodily fluids such as saliva, urine, or reproductive secretions. The bacteria can enter the human body through cuts or abrasions on the skin, mucous membranes, or via inhalation. Dog breeders, veterinarians, or pet owners who handle infected dogs are at higher risk of contracting this disease. Transmission is less common from other animals, and the disease is not typically spread from person to person.

Key Symptoms: The symptoms of brucellosis caused by Brucella canis can vary widely and may include: - Fever that persists or recurs - Fatigue and general weakness - Loss of appetite - Swelling and pain in joints, especially in the knees, hips, or elbows - Muscle pain - Swollen lymph nodes - Enlarged spleen or liver - Recurrent chills - In some cases, it may cause inflammation of the testicles in male patients - In chronic cases, symptoms may develop slowly and persist for months or years, leading to more severe health issues It is important to note that some individuals may experience mild symptoms or remain asymptomatic, particularly in early stages.

Diagnostic & Treatment

Diagnosis Path: Diagnosing brucellosis due to Brucella canis involves a combination of clinical assessment and laboratory tests. Healthcare providers typically consider a person's exposure history, especially contact with dogs known or suspected to be infected. Diagnostic steps may include: - Blood tests to detect antibodies against Brucella canis - Culture tests to identify the bacteria from blood, tissue, or bodily fluids - Polymerase chain reaction (PCR) tests that detect bacterial DNA - Imaging studies such as ultrasound or X-rays in cases of joint or organ involvement Timely diagnosis is crucial to prevent complications and to initiate appropriate management.

Treatment Protocols: Treatment for brucellosis due to Brucella canis generally involves a course of antibiotics aimed at eradicating the bacteria. The typical treatment plan may include: - Administration of doxycycline combined with an aminoglycoside such as streptomycin or gentamicin - Depending on the severity and duration of infection, other antibiotics like rifampin or trimethoprim-sulfamethoxazole may be used - Duration of treatment often extends for at least 6 weeks to ensure complete eradication - Monitoring for signs of relapse or persistent infection is essential - Supportive care may include rest, hydration, and pain management As with all infectious diseases, early detection and adherence to prescribed treatment are vital for better outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A23.3 a billable ICD-10 code?
Yes, A23.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A23.3?
Clinical documentation must specify the nature of Brucellosis due to Brucella canis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

brucellosis brucella canis